news 
Nasdaq-listed MEI Pharma launches $100M Litecoin treasury plan, stock rockets 50%
July 18, 2025 – In a surprising move, biotech company MEI Pharma announced today that it is launching a massive $100 million Litecoin treasury plan in partnership with the Litecoin Foundation and major crypto partners. This unprecedented decision has sent shockwaves through the markets, as MEI Pharma’s stock price has skyrocketed by an astonishing 50% at market opening.
According to sources close to the matter, this bold move is aimed at expanding global Litecoin adoption through institutional channels. To facilitate this, Charlie Lee, the creator of Litecoin, will be joining MEI Pharma’s Board of Directors.
The massive $100 million treasury plan represents a significant vote of confidence in Litecoin’s potential and its ability to disrupt traditional financial systems. The partnership with MEI Pharma and other key players in the crypto space is expected to unlock new opportunities for institutional investors and pave the way for a mainstream adoption of cryptocurrency in the biotech industry.
The news has sent ripples through the markets, as investors scramble to get in on the action. The rapid rise in stock price is a testament to the power of this bold move by MEI Pharma.
MEI Pharma’s decision marks a significant milestone in the crypto landscape, as it becomes the first Nasdaq-listed company to establish a treasury plan dedicated solely to Litecoin. This development comes as no surprise given the growing interest in cryptocurrency from institutional investors and mainstream companies.
The article is based on the provided data, but it does not reflect any real event or partnership between MEI Pharma and Litecoin.
Source: cryptobriefing.com
